西班牙威尔逊病患者的生殖和怀孕控制
Marta Romero-Gutiérrez1, Pablo Alonso2, Marina Berenguer3
1Complejo Hospitalario Universitario de Toledo, Gastroenterology and Hepatology Department, Toledo.
European journal of gastroenterology & hepatology
|August 21, 2024
概括
威尔逊病的西班牙妇女怀孕和哺乳期的管理不一致,与国际指导方针不同. 对这种罕见的肝病的患者教育对于标准化护理至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生殖医学 生殖医学
- 罕见疾病 罕见疾病
背景情况:
- 怀孕,哺乳期和避孕期间对威尔逊病管理的国际指南并不统一.
- 关于西班牙威尔逊病患者生殖健康管理的数据有限.
研究的目的:
- 研究西班牙威尔逊病妇女的生殖和妊娠经历.
- 为了确定当前的做法和挑战在管理怀孕,哺乳期和避孕在这个人口.
主要方法:
- 从西班牙威尔逊登记处进行了一项涉及92名患有威尔逊病的成年女性的多中心,两样性研究.
- 数据收集包括关于避孕,生育,怀孕和哺乳的采访,并补充了临床和分析注册数据.
主要成果:
- 63%的女性有怀孕史,流产率为21.6%,未被诊断的患者的流产率更高.
- 大多数孕妇都接受了化剂治疗,很少建议降低剂量.
- 人工哺乳是常见的 (60.3%),以医生建议为指导.
结论:
- 西班牙对威尔逊病的妊娠管理非常多变,经常偏离国际标准.
- 需要改善罕见肝病的教育和标准化建议,以确保一致的患者护理.
相关概念视频
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


